vs

Side-by-side financial comparison of TANDEM DIABETES CARE INC (TNDM) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $247.2M, roughly 1.0× TANDEM DIABETES CARE INC). USA Compression Partners, LP runs the higher net margin — 11.0% vs -8.2%, a 19.2% gap on every dollar of revenue. On growth, TANDEM DIABETES CARE INC posted the faster year-over-year revenue change (5.5% vs 2.7%). Over the past eight quarters, TANDEM DIABETES CARE INC's revenue compounded faster (5.5% CAGR vs 4.9%).

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

TNDM vs USAC — Head-to-Head

Bigger by revenue
USAC
USAC
1.0× larger
USAC
$252.5M
$247.2M
TNDM
Growing faster (revenue YoY)
TNDM
TNDM
+2.8% gap
TNDM
5.5%
2.7%
USAC
Higher net margin
USAC
USAC
19.2% more per $
USAC
11.0%
-8.2%
TNDM
Faster 2-yr revenue CAGR
TNDM
TNDM
Annualised
TNDM
5.5%
4.9%
USAC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
TNDM
TNDM
USAC
USAC
Revenue
$247.2M
$252.5M
Net Profit
$-20.4M
$27.8M
Gross Margin
55.3%
Operating Margin
37.6%
30.3%
Net Margin
-8.2%
11.0%
Revenue YoY
5.5%
2.7%
Net Profit YoY
9.1%
EPS (diluted)
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TNDM
TNDM
USAC
USAC
Q1 26
$247.2M
Q4 25
$290.4M
$252.5M
Q3 25
$249.3M
$250.3M
Q2 25
$240.7M
$250.1M
Q1 25
$234.4M
$245.2M
Q4 24
$282.6M
$245.9M
Q3 24
$244.0M
$240.0M
Q2 24
$221.9M
$235.3M
Net Profit
TNDM
TNDM
USAC
USAC
Q1 26
$-20.4M
Q4 25
$-589.0K
$27.8M
Q3 25
$-21.2M
$34.5M
Q2 25
$-52.4M
$28.6M
Q1 25
$-130.6M
$20.5M
Q4 24
$755.0K
$25.4M
Q3 24
$-23.3M
$19.3M
Q2 24
$-30.8M
$31.2M
Gross Margin
TNDM
TNDM
USAC
USAC
Q1 26
55.3%
Q4 25
57.7%
Q3 25
53.9%
Q2 25
52.3%
Q1 25
50.5%
Q4 24
55.7%
Q3 24
51.1%
Q2 24
50.8%
Operating Margin
TNDM
TNDM
USAC
USAC
Q1 26
37.6%
Q4 25
2.9%
30.3%
Q3 25
-9.2%
33.5%
Q2 25
-21.5%
30.6%
Q1 25
-51.6%
28.3%
Q4 24
-0.2%
30.3%
Q3 24
-10.7%
31.5%
Q2 24
-13.9%
32.9%
Net Margin
TNDM
TNDM
USAC
USAC
Q1 26
-8.2%
Q4 25
-0.2%
11.0%
Q3 25
-8.5%
13.8%
Q2 25
-21.8%
11.4%
Q1 25
-55.7%
8.4%
Q4 24
0.3%
10.3%
Q3 24
-9.5%
8.1%
Q2 24
-13.9%
13.3%
EPS (diluted)
TNDM
TNDM
USAC
USAC
Q1 26
$-0.30
Q4 25
$0.02
Q3 25
$-0.31
Q2 25
$-0.78
Q1 25
$-1.97
Q4 24
$0.00
Q3 24
$-0.35
Q2 24
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TNDM
TNDM
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$570.3M
$8.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$132.4M
Total Assets
$1.2B
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TNDM
TNDM
USAC
USAC
Q1 26
$570.3M
Q4 25
$292.7M
$8.6M
Q3 25
$319.1M
Q2 25
$315.4M
$2.0K
Q1 25
$368.6M
$2.0K
Q4 24
$438.3M
$14.0K
Q3 24
$473.3M
$79.0K
Q2 24
$452.4M
$9.0K
Total Debt
TNDM
TNDM
USAC
USAC
Q1 26
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Stockholders' Equity
TNDM
TNDM
USAC
USAC
Q1 26
$132.4M
Q4 25
$155.2M
Q3 25
$133.0M
Q2 25
$133.3M
Q1 25
$155.3M
Q4 24
$263.1M
Q3 24
$237.7M
Q2 24
$233.9M
Total Assets
TNDM
TNDM
USAC
USAC
Q1 26
$1.2B
Q4 25
$881.1M
$2.6B
Q3 25
$874.7M
$2.7B
Q2 25
$875.7M
$2.7B
Q1 25
$922.1M
$2.7B
Q4 24
$967.7M
$2.7B
Q3 24
$957.7M
$2.8B
Q2 24
$937.5M
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TNDM
TNDM
USAC
USAC
Operating Cash FlowLast quarter
$139.5M
Free Cash FlowOCF − Capex
$87.7M
FCF MarginFCF / Revenue
34.8%
Capex IntensityCapex / Revenue
2.5%
20.5%
Cash ConversionOCF / Net Profit
5.02×
TTM Free Cash FlowTrailing 4 quarters
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TNDM
TNDM
USAC
USAC
Q1 26
Q4 25
$9.8M
$139.5M
Q3 25
$8.3M
$75.9M
Q2 25
$-9.5M
$124.2M
Q1 25
$-18.3M
$54.7M
Q4 24
$10.7M
$130.2M
Q3 24
$26.8M
$48.5M
Q2 24
$-5.3M
$96.7M
Free Cash Flow
TNDM
TNDM
USAC
USAC
Q1 26
Q4 25
$3.1M
$87.7M
Q3 25
$4.2M
$51.9M
Q2 25
$-15.7M
$101.1M
Q1 25
$-21.2M
$36.3M
Q4 24
$7.6M
$101.2M
Q3 24
$21.5M
$19.8M
Q2 24
$-11.7M
$48.2M
FCF Margin
TNDM
TNDM
USAC
USAC
Q1 26
Q4 25
1.1%
34.8%
Q3 25
1.7%
20.7%
Q2 25
-6.5%
40.4%
Q1 25
-9.1%
14.8%
Q4 24
2.7%
41.1%
Q3 24
8.8%
8.2%
Q2 24
-5.3%
20.5%
Capex Intensity
TNDM
TNDM
USAC
USAC
Q1 26
2.5%
Q4 25
2.3%
20.5%
Q3 25
1.6%
9.6%
Q2 25
2.6%
9.3%
Q1 25
1.3%
7.5%
Q4 24
1.1%
11.8%
Q3 24
2.1%
12.0%
Q2 24
2.9%
20.6%
Cash Conversion
TNDM
TNDM
USAC
USAC
Q1 26
Q4 25
5.02×
Q3 25
2.20×
Q2 25
4.35×
Q1 25
2.66×
Q4 24
14.19×
5.12×
Q3 24
2.51×
Q2 24
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TNDM
TNDM

Segment breakdown not available.

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons